国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

USEUROPEAFRICAASIA 中文雙語Fran?ais
Lifestyle
Home / Lifestyle / News

Shortage of life-saving heart drug

By Zhou Wenting | China Daily | Updated: 2011-09-13 11:11

BEIJING - Experts have called for a national drug-control system after a nationwide deficit of a life-saving drug, which has lasted at least three months.

Doctors at a Beijing hospital said some specialized hospitals, which perform hundreds of cardiac operations every month, have been paralyzed by their lack of protamine sulfate, which is commonly administered after heart surgery to reverse the anticoagulant effects of heparin.

The earliest report of a shortage was in Hubei province on July 21. This was followed by reports of shortages in Guangdong, Shandong and Liaoning provinces.

The Shandong newspaper, Qilu Evening News, quoted a regional sales manager, surnamed Zhuang, as saying the province had been allocated 150 doses of protamine sulfate after Shanghai No 1 Biochemical and Pharmaceutical Co Ltd recently resumed production of the drug.

"But its monthly use here is usually 10,000 doses," he said.

The Ministry of Health has denied it is responsible for supplies of the drug and passed the buck to the State Food and Drug Administration, claiming the latter is responsible for the supervision of medicines.

Shen Chen, head of the publicity office of the State Food and Drug Administration, said he was unaware of the shortage, but said the administration is responsible for the quality of medicines, not the supply.

"Development and reform authorities oversee the medicines' prices, while the industrial and commercial authorities oversee the storage. The food and drug departments only cover the approval and quality of medicines."

Industry insiders said one of the reasons for the shortage was the low profit margin, which discourages companies from mass producing the drug.

"Some companies can't earn enough to recover their costs, therefore it is almost impossible to maintain their enthusiasm for continuing production," said Lu Guoping, secretary-general of the Shanghai Pharmaceutical Trade Association.

Lu said the government should issue policies to prevent future shortages of such medicines to avoid possible nationwide public health incidents.

Yi Shenghua, a lawyer at Beijing Yingke Law Firm, said the country should have a unified system to guarantee the normal supply of medicines that are widely used and drug manufacturers should fulfill their responsibilities to society, even though there is no law stipulating they should produce specific medicines.

He came up with two ways to deal with the problem of companies only producing profitable drugs.

"The government can order businesses to manufacture a certain amount of cheap medicines. Or it can offer financial assistance to subsidize cheap, but life-saving medicines."

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
南城县| 额尔古纳市| 柘城县| 宣恩县| 彭泽县| 保德县| 聂拉木县| 盐亭县| 庐江县| 宣武区| 井研县| 望江县| 喀喇| 龙州县| 绥棱县| 墨竹工卡县| 汕尾市| 饶阳县| 宜阳县| 曲麻莱县| 沂水县| 尼勒克县| 洛阳市| 额敏县| 扬州市| 云阳县| 大化| 上杭县| 师宗县| 辽中县| 永兴县| 平安县| 五大连池市| 成都市| 托里县| 乌海市| 安庆市| 怀集县| 洛隆县| 内丘县| 临猗县|